WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	265.02B
Revenue (ttm)	41.90B
Net Income (ttm)	13.77B
Shares Out	2.92B
EPS (ttm)	3.99
PE Ratio	19.82
Forward PE	19.02
Dividend	0.98 (1.09%)
Ex-Dividend Date	May 21, 2025

Volume	131,165,425
Average Volume	68,079,989
Open	97.15
Previous Close	96.98
Day's Range	90.01 - 99.00
52-Week Range	36.86 - 102.49
Beta	0.73
RSI	52.09
Earnings Date	Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.